Ambuja Cements (AMBUJACEM) — Board Meeting

Ambuja Cements' Finance Committee approved allotment of 87 million equity shares at ₹2 face value to Adani Cementation Limited shareholders under the approved amalgamation scheme. The NCLT sanctioned this merger on July 18, 2025. Paid-up equity capital increased from 246.31 crores to 247.18 crores shares. New shares rank pari passu with existing shares and will be listed on BSE and NSE.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AMBUJACEM ✨ Ask AI About This

About Ambuja Cements Limited (AMBUJACEM)

Construction Materials · Cement & Cement Products · Listed on NSE

Market Cap: ₹1,07,215.34 Cr P/E: 23.3 ROE: 7.7% ROCE: 4.6%

View full AMBUJACEM stock details →

📡 Get AI alerts when AMBUJACEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AMBUJACEM — Free

💡 Ask AI about this filing

"How does this board meeting affect Ambuja Cements Limited's outlook?" "What did Ambuja Cements Limited announce on 2 August 2025?" "Is this positive or negative for AMBUJACEM?"

Ask AI Free →

📊 More AMBUJACEM filings

See all AMBUJACEM filings →

🔥 Also filed on 2 August 2025

TATAPOWER Tata Power Company Limited Financial Results VEDL Vedanta Limited Financial Results ASIANPAINT Asian Paints Limited Financial Results TATAPOWER Tata Power Company Limited Financial Results BRITANNIA Britannia Industries Limited Financial Results CIPLA Cipla Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AMBUJACEM files new disclosures

Track AMBUJACEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.